2026-2030年全球細胞分離市場

全球細胞分級市場預計在 2025 年至 2030 年間成長至 175,458,100 美元，預測期內複合年成長率為 8.5%。

本報告對全球細胞保存市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家供應商的分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括：對個人化醫療和標靶免疫療法的需求不斷成長；全球細胞和基因療法臨床試驗的快速擴張；以及公共和私人對先進生物醫學研究投資的激增。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，人工智慧與微流體技術創新融合是未來幾年全球細胞分選市場成長的關鍵促進因素之一。此外，小型化、方便用戶使用的桌上型細胞分選平台的發展趨勢，以及為提高生物安全性和無菌性而日益普及的封閉式系統結構，預計也將顯著提升市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球細胞分級市場
• 2020-2024 年最終用戶細分市場分析
• 2020-2024年基於技術的細分市場分析
• 產品細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球細胞分離市場
• 地緣政治衝突的影響：全球細胞提取市場

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 製藥和生物技術公司
• 醫院和檢測機構
• 其他
• 市場機會：依最終用戶分類

第9章 市場區隔：依技術分類

• 比較：按技術
• FADS
• MACS
• MEMS
• 市場機會：依技術分類

第10章 市場區隔：依產品

• 比較：按產品
• 耗材和試劑
• 裝置
• 軟體服務
• 市場機會：依產品分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• A. Menarini Industrie Farma
• Apogee Flow Systems Ltd.
• Beckman Coulter Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Fluigent SA
• Meteor Biotech
• Miltenyi Biotec BV and Co. KG
• NanoCellect Biomedical Inc.
• Nova Biomedical Corp.
• Sony Biotechnology Inc.
• STEMCELL Technologies Inc.
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Union Biometrica Inc.

第16章附錄

The global cell sorting market is forecasted to grow by USD 175458.1 thousand during 2025-2030, accelerating at a CAGR of 8.5% during the forecast period. The report on the global cell sorting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating demand for personalized medicine and targeted immunotherapies, rapid expansion of cell and gene therapy clinical trials worldwide, surge in public and private investments for advanced biomedical research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cell sorting market is segmented as below:

By End-User

• Pharma and biotech companies
• Hospitals and testing labs
• Others

By Technology

• FADS
• MACS
• MEMS

By Product

• Consumables and reagents
• Instruments
• Software and services

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and microfluidic innovations as one of the prime reasons driving the global cell sorting market growth during the next few years. Also, transition toward compact and user friendly benchtop cell sorting platforms and rising adoption of closed system architectures for enhanced biosafety and sterility will lead to sizable demand in the market.

The report on the global cell sorting market covers the following areas:

• Global cell sorting market sizing
• Global cell sorting market forecast
• Global cell sorting market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cell sorting market vendors that include A. Menarini Industrie Farma, Apogee Flow Systems Ltd., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Cytonome ST LLC, Elvesys SAS, Fluigent SA, Meteor Biotech, Miltenyi Biotec BV and Co. KG, NanoCellect Biomedical Inc., Nova Biomedical Corp., On Chip Biotechnologies Co. Ltd., RainBio Solutions, Sony Biotechnology Inc., STEMCELL Technologies Inc., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., ThinkCyte K.K., Union Biometrica Inc.. Also, the global cell sorting market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cell Sorting Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cell Sorting Market 2020 - 2024 ($ thousand)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.3 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ thousand)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on global cell sorting market
• 6.2 Impact of geopolitical conflicts on global cell sorting market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 8.4 Hospitals and testing labs - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

9 Market Segmentation by Technology

• 9.1 Market segments
• 9.2 Comparison by Technology
• 9.3 FADS - Market size and forecast 2025-2030
• 9.4 MACS - Market size and forecast 2025-2030
• 9.5 MEMS - Market size and forecast 2025-2030
• 9.6 Market opportunity by Technology
  • Market opportunity by Technology ($ thousand)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Consumables and reagents - Market size and forecast 2025-2030
• 10.4 Instruments - Market size and forecast 2025-2030
• 10.5 Software and services - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Indonesia - Market size and forecast 2025-2030
  • 12.4.6 Thailand - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating demand for personalized medicine and targeted immunotherapies
  • Rapid expansion of cell and gene therapy clinical trials worldwide
  • Surge in public and private investments for advanced biomedical research
• 13.2 Market challenges
  • Prohibitive instrumentation costs and shortage of specialized personnel
  • Absence of standardized protocols across complex cytometric workflows
  • Difficulties associated with high dimensional data management and interpretation
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of AI and microfluidic innovations
  • Transition toward compact and user friendly benchtop cell sorting platforms
  • Rising adoption of closed system architectures for enhanced biosafety and sterility

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 A. Menarini Industrie Farma
  • A. Menarini Industrie Farma - Overview
  • A. Menarini Industrie Farma - Product / Service
  • A. Menarini Industrie Farma - Key offerings
  • SWOT
• 15.5 Apogee Flow Systems Ltd.
  • Apogee Flow Systems Ltd. - Overview
  • Apogee Flow Systems Ltd. - Product / Service
  • Apogee Flow Systems Ltd. - Key offerings
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.9 Fluigent SA
  • Fluigent SA - Overview
  • Fluigent SA - Product / Service
  • Fluigent SA - Key offerings
  • SWOT
• 15.10 Meteor Biotech
  • Meteor Biotech - Overview
  • Meteor Biotech - Product / Service
  • Meteor Biotech - Key offerings
  • SWOT
• 15.11 Miltenyi Biotec BV and Co. KG
  • Miltenyi Biotec BV and Co. KG - Overview
  • Miltenyi Biotec BV and Co. KG - Product / Service
  • Miltenyi Biotec BV and Co. KG - Key offerings
  • SWOT
• 15.12 NanoCellect Biomedical Inc.
  • NanoCellect Biomedical Inc. - Overview
  • NanoCellect Biomedical Inc. - Product / Service
  • NanoCellect Biomedical Inc. - Key offerings
  • SWOT
• 15.13 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.14 Sony Biotechnology Inc.
  • Sony Biotechnology Inc. - Overview
  • Sony Biotechnology Inc. - Product / Service
  • Sony Biotechnology Inc. - Key offerings
  • SWOT
• 15.15 STEMCELL Technologies Inc.
  • STEMCELL Technologies Inc. - Overview
  • STEMCELL Technologies Inc. - Product / Service
  • STEMCELL Technologies Inc. - Key offerings
  • SWOT
• 15.16 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Union Biometrica Inc.
  • Union Biometrica Inc. - Overview
  • Union Biometrica Inc. - Product / Service
  • Union Biometrica Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations